Get started
Author

Tanja Kaartinen

Observed names: T Kaartinen, T. Kaartinen, Tanja Smedberg
Institution: Finnish Red Cross
ORCID: 0000-0001-8985-7585
Observed ORCID: 0000-0001-8985-7585
OpenAlex ID: A5046195686
Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: A prospective and randomized clinical study
2005 · Katri Kaukinen, Markku Peräaho, et al. · Scandinavian Journal of Gastroenterology · 155
Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion
2017 · Tanja Kaartinen, Annu Luostarinen, et al. · Cytotherapy · 126
PDF
Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit
2007 · Katri Kaukinen, Pekka Collin, et al. · Scandinavian Journal of Gastroenterology · 89
The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes
2019 · Sofia Oja, Tanja Kaartinen, et al. · Frontiers in Immunology · 68
PDF
A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells
2015 · Anita Laitinen, Sofia Oja, et al. · Cytotechnology · 62
PDF
The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency
2008 · K Haimila, E Einarsdottir, et al. · Genes and Immunity · 52
Performance of a new rapid whole blood coeliac test in adult patients with low prevalence of endomysial antibodies
2007 · T. Raivio, I. Korponay-Szabó, et al. · Digestive and Liver Disease · 41
T cell regeneration in pediatric allogeneic stem cell transplantation
2007 · H Olkinuora, K Talvensaari, et al. · Bone Marrow Transplantation · 34
Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety
2018 · Joni Keto, Tanja Kaartinen, et al. · Molecular Therapy — Methods & Clinical Development · 31
PDF
Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4
2006 · Tanja Kaartinen, Jani Lappalainen, et al. · Molecular Immunology · 29
Eosinophil Cationic Protein in Human Milk Is Associated with Development of Cow's Milk Allergy and Atopic Eczema in Breast-fed Infants
2003 · Pamela Österlund, Tanja Smedberg, et al. · Pediatric Research · 28
Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion
2017 · Tanja Kaartinen, Annu Luostarinen, et al. · Cytotherapy · 25
ATMP-classified, scalable, autologous cell spray for the treatment of skin wounds and assessment of its effects on wound healing clinically and on a molecular level
2022 · Kristo Nuutila, Shintaro Katayama, et al. · Burns · 10
PDF
Donor selection and release criteria of cellular therapy products
2012 · H. Eichler, H. Schrezenmeier, et al. · Vox Sanguinis · 9
Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing
2024 · Annu Luostarinen, Anssi Kailaanmäki, et al. · Cytotherapy · 6
PDF
The utilization of freezing steps in mesenchymal stromal cell (MSC) manufacturing: Potential impact on quality and cell functionality attributes
2017 · S. Oja, A. Laitinen, et al. · Cytotherapy · 6
Low IL-2 concentration favors generation of early memory T cells over terminal effectors during CAR T-cell expansion
2017 · A. Luostarinen, T. Kaartinen, et al. · Cytotherapy · 2
In Vitro Cell Expansion and CTLA4 in Advanced T-Cell Therapies
2017 · Tanja Kaartinen · Työväentutkimus Vuosikirja · 1
In Vitro Treg Expansion Favors the Full-Length Splicing Isoform of CTLA4
2016 · Tanja Kaartinen, Heidi Harjunpää, et al. · Immunotherapy · 1
Thymic Recovery among Pediatric Stem Cell Recipients.
2005 · Helena Olkinuora, Tanja Kaartinen, et al. · Blood · 1
Immunomonitoring of patients treated with mesenchymal stromal cells for steroid-refractory severe graft-versus-host disease
2017 · J Keto, T Kaartinen, et al. · Cytotherapy
Cell culture confluency level and the variability of platelet lysate pools impact the readout of the ostegenic differentiation assay of mesenchymal stromal cells
2017 · A. Laitinen, T. Kaartinen, et al. · Cytotherapy
Impact of starting material and expansion conditions on cell yield and composition of CAR T cell products
2016 · Tanja Kaartinen, Annu Luostarinen, et al. · Scandinavian Journal of Immunology
Works count: 23
Citation count: 776
H-index: 12
I10-index: 13
Year
Topic
Type